| 查看: 477 | 回复: 1 | |||
yaoguiyang木虫 (小有名气)
|
[求助]
求助构效关系的翻译
|
|
The Cyp binding domain of CsA comprises of residues 9, 10, 11, 1 and 2; hence, altering these residues tends to have a significant effect on Cyp binding. Modifications to residues in the CN binding domain (4, 5, 6, and 7), on the other hand, influence Cyp binding indirectly through effects on conformation, but often exert a more profound affect on CN binding. The (4R)-4-[(E)-2-butenyl]-4- methyl-L-threonine (MeBmt) group at position 1 is unique in that it resides in the Cyp binding domain, yet its sidechain drapes across the CsA scaffold and ultimately into the CN binding domain (Fig. 4). In general, modifications to MeBmt tend to decrease Cyp binding. Removing or altering the stereochemistry of the 2-methyl group reduces activity, as does introducing a second methyl group at this position.54 Likewise, removing, replacing, or capping the 30- hydroxy as an ester also reduces potency.55 One case in which Cyp binding is actually improved is when the C@C double bond is replaced with a bioisosteric sulfur atom (‘MeThiaBmt’), which was found to bind to Cyp with 178% of the affinity of CsA itself.54b The [Sar]3 position lies on the periphery on the Cyp binding domain, and consequently structural changes at [Sar]3 can directly, or indirectly through conformational bias, impact Cyp binding. Substitution at the 20-, or a-carbon of [Sar]3 is extremely welltolerated, provided that it resides on the b-face to give the Re, or D-configuration; substitution on the a-face that gives the Si, or L-configuration, results in steric clashing between this substituent and the N-methyl group of [MeLeu]4, and hence an altered conformation of the CsA scaffold that does not bind Cyp as well.56 Both [D-MeAla]3CsA and [D-MePhe]3CsA bind to Cyp with affinity comparable to that of CsA,55a while [D-MeSer]3CsA binds to Cyp with over threefold greater affinity than CsA.57 This is an important attribute that has been exploited in the design of CsA-based therapeutics. |
回复此楼» 猜你喜欢
关于filecode，很负责任的告诉大家
已经有7人回复
-
【2027博士申请】纳米药物递送方向
已经有5人回复
-
关于豆爷回答的JTJC与%2F数量
已经有7人回复
-
2026国自然放榜时间
已经有3人回复
-
国基金的申报应该改成非等额制，评价高的钱多评价低的钱少，但是增加资助率
已经有7人回复
-
好奇怪的filecode
已经有4人回复
-
售SCI文章，我:8O5.5.1.O.54,科目齐全,可+急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O54,科目全,可伽急
已经有4人回复
-
售SCI文章，我:8O.5.5.1O.54,科目全,可十急
已经有4人回复
-
售SCI一区T0P文章，我:8.O.55.1.O.54,科目齐全,可+急
已经有5人回复
yaoguiyang
木虫 (小有名气)
 |
2楼2014-11-30 11:07:14
100